During the past decade, Josa Andras Oktatokorhaz conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 21 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 10 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Josa Andras Oktatokorhaz" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Pfizer" with 7 trials sponsored, "Bayer" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Ipsen" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Josa Andras Oktatokorhaz" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cordis Corporation" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Josa Andras Oktatokorhaz" are "Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Cardiovascular Disease" (2 trials), "Cervical Dystonia" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Josa Andras Oktatokorhaz" in a lesser frequency.

Most popular intervention types in "Josa Andras Oktatokorhaz" are "Drug" (35 trials), "Other" (6 trials), "Biological" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Bevacizumab" (4 trials), "BMS-986165" (2 trials), "Botulinum toxin type A" (2 trials) and "Capecitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Josa Andras Oktatokorhaz" are 36 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Josa Andras Oktatokorhaz". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Josa Andras Oktatokorhaz, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Josa Andras Oktatokorhaz, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".